Simplex Trading’s LENZ Therapeutics LENZ Stock Holding History

Simplex Trading’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$63.4K	Buy	+6,927	New	+$97.3K	﹤0.01%	5603
2025 Q4	–	Sell	-2,147	Closed	-$62.6K	–	10342
2025 Q3	$100K	Buy	+2,147	New	+$78.9K	﹤0.01%	5753
2024 Q1	–	Sell	-10	Closed	–	–	10096
2023 Q4	$0	Sell	10 -17	-63%	-$281	﹤0.01%	10021
2023 Q3	$0	Buy	+27	New	+$470	﹤0.01%	10036
2023 Q1	–	Sell	-478	Closed	-$7.73K	–	10314
2022 Q4	$11K	Sell	478 -4,970	-91%	-$115K	﹤0.01%	7484
2022 Q3	$120K	Sell	5,448 -4,422	-45%	-$105K	﹤0.01%	5271
2022 Q2	$189K	Buy	+9,870	New	+$220K	﹤0.01%	4688

Other funds holding LENZ

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

7IH

72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Simplex Trading's LENZ Position: Q1 2026 in Review

Simplex Trading opened a new position in LENZ Therapeutics (LENZ) in Q1 2026: 6,927 shares worth $63.4K. The stake represents ﹤0.01% of the portfolio and ranks #5603 among its holdings. This is a return to the name: Simplex Trading previously reported a position in LENZ as recently as Q3 2025.

Simplex Trading first reported a position in LENZ in Q2 2022 and has held it in 7 quarters since. The position peaked at $189K in Q2 2022. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

Simplex Trading held 6,927 shares of LENZ Therapeutics worth $63.4K as of Q1 2026.
LENZ Therapeutics was a new Simplex Trading position in Q1 2026.
LENZ Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5603 holding.
Simplex Trading first reported a position in LENZ Therapeutics in Q2 2022 and has held it in 7 quarters since.
Simplex Trading's LENZ Therapeutics position peaked at $189K in Q2 2022.
145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.